C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
12/1999
12/23/1999	WO1999065870A2 Sulfonamide inhibitors of aspartyl protease
12/22/1999	EP0964849A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
12/22/1999	EP0765858B1 Naphthol derivatives and process for producing the same
12/22/1999	EP0733033B1 Pharmaceutically active substituted aromatic compounds
12/22/1999	EP0635018B1 4-(1H-2-METHYLIMIDAZO[4,5-c]PYRIDINYLMETHYL)PHENYLSULPHONAMIDE DERIVATIVES AS ANTAGONISTS OF PAF
12/21/1999	US6005008 Aromatic urea compounds
12/21/1999	US6004957 Sulfonamide inhibitors of aspartyl protease
12/21/1999	US6004948 Derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase II
12/16/1999	WO1999064442A1 Peptide inhibitors of hepatitis c virus ns3 protease
12/16/1999	WO1999064394A1 Neuropeptide y5 receptor antagonists
12/16/1999	WO1999064390A1 Phenylalanine derivatives as integrin inhibitors
12/16/1999	WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	WO1999064050A1 Novel potassium channel drugs and their uses
12/16/1999	WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999	WO1999064038A1 Novel analgesic agents
12/16/1999	WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	WO1999063999A1 H1-histamine receptor antagonists
12/16/1999	WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999	WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999	CA2330247A1 Peptide inhibitors of hepatitis c virus ns3 protease
12/16/1999	CA2321273A1 Novel analgesic agents
12/16/1999	CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999	CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	CA2319651A1 H1-histamine receptor antagonists
12/16/1999	CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999	CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999	CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2318745A1 Novel potassium channel drugs and their uses
12/16/1999	CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999	CA2318055A1 .beta.2-adrenergic receptor agonists
12/15/1999	EP0963370A1 Integrin antagonists
12/15/1999	CN1238761A Benzamidoaldehydes and their use as cryteine protease inhibitors
12/15/1999	CN1238688A Thiol sulfonamide metalloprotease inhibitors
12/14/1999	US6002014 Selectively inhibiting the action of cox-2; treating inflammation
12/14/1999	US6001881 Administering to treat arrhythmia, angina pectoris, ischemia, shock, cell proliferation, fibrotic diseases, prostate hyperplasia, fat metabolism disorders, and as a preservative for transplant organs, or to prepare a patient for surgery
12/14/1999	US6001877 Of given formula, which acts as an antagonist of leukotrienes; administering to treat leukotriene-b4 induced diseases, such as allergies and inflammation
12/14/1999	US6001347 Organic acid compound of given structure having an aromatic amide group, a methoxy group in the ortho position on the aromatic ring, and a lipophilic chain terminated with a carboxylic acid is useful as a nontoxic carrier
12/09/1999	WO1999062873A1 Benzenesulphonamide derivatives as pyruvate dehydrogenase activators
12/09/1999	WO1999062872A1 New 3-aryl-2-hydroxypropionic acid derivative (i)
12/09/1999	WO1999062871A1 New 3-aryl propionic acid derivatives and analogs
12/09/1999	WO1999062870A1 New 3-aryl-2-hydroxypropionic acid derivative iii
12/09/1999	WO1999062864A1 Chemical process for the stereoselective synthesis of r-(-)-carnitine
12/09/1999	WO1999043285A3 Sulphonamide derivatives
12/09/1999	CA2334374A1 New 3-aryl propionic acid derivatives and analogs
12/09/1999	CA2334107A1 New 3-aryl-2-hydroxypropionic acid derivative iii
12/09/1999	CA2333572A1 Chemical process for the stereoselective synthesis of r-(-)-carnitine
12/08/1999	EP0712387B1 2-aminoindans as selective dopamine d3 ligands
12/08/1999	CN1237961A Aminoguanidines and alkoxyguanidines as protease inhibitors
12/08/1999	CN1047166C Improved process for making sulfonyl isocyanates
12/07/1999	US5998665 Therapy for nervous system disorders
12/07/1999	US5998481 Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
12/07/1999	US5998470 Osteoporosis; oral diseases; antiarthritic agents
12/07/1999	US5998410 Sulfonamide derivatives
12/02/1999	WO1999061413A1 Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
12/02/1999	WO1999061406A2 Antiangiogenic drug to treat cancer, arthritis and retinopathy
11/1999
11/30/1999	US5994583 First step is a catalyzed asymmetric aminohydroxylation addition reaction to an olefin substrate
11/30/1999	US5994582 Preparation of substituted guanidine derivative
11/30/1999	US5994398 Alzheimer's disease
11/30/1999	US5994381 Antipyretics; antiinflammatory agents; analgesics
11/30/1999	US5994351 Antiarthritic agents; anticancer agents; antiulcer agents; enzyme inhibitors
11/30/1999	US5994294 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
11/30/1999	US5993780 Contrast media
11/25/1999	WO1999059964A1 Novel analogs of 16-hydroxyeicosatetraenoic acid
11/25/1999	WO1999059959A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/25/1999	WO1999059957A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
11/25/1999	WO1999059576A1 Aryl nitrone therapeutics for the treatment of inflammatory bowel disease
11/25/1999	WO1999059526A2 Protease inhibitors
11/25/1999	DE3943678C2 New isoquinoline:sulphonamide and naphthalene:sulphonamide cpds.
11/25/1999	CA2332531A1 Protease inhibitors
11/25/1999	CA2332462A1 Aryl nitrone therapeutics for the treatment of inflammatory bowel disease
11/25/1999	CA2332272A1 Novel analogs of 16-hydroxyeicosatetraenoic acid
11/24/1999	EP0957908A1 Fibrinogen receptor antagonists
11/23/1999	US5990353 Demetallizing an arylsulfonamide alkali metal salt with an aromatic isocyanate compound in at least one solvent; use as a color developer for a thermal recording material with improved oil resistance and nonplasticized
11/23/1999	US5990158 Carboxylic acid derivatives, method of manufacturing the same and therapeutic agents containing these compounds
11/23/1999	US5990083 Composition for reducing cu/zn superoxide dismutase-1 enzyme degradation by inhibiting multicatalytic protease; treating muscle wasting diseases associated with low superoxide dismutase-1 enzyme activity
11/23/1999	US5989539 Compounds and compositions for delivering active agents
11/18/1999	WO1999058924A1 Inductance measurement
11/18/1999	WO1999058499A1 Phenylsulfonamide-phenylethylamines useful as dopamine receptors
11/18/1999	WO1999058496A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999	WO1999058495A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999	CA2327345A1 Phenylsulfonamide-phenylethylamines useful as dopamine receptors

1 ... 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 ... 177